Healthcare & Life Sciences Funding

Capvizr tracks Healthcare & Life Sciences funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Recent Healthcare & Life Sciences rounds

• UltraSight · $24 million · Series B2 · September 28, 2026
• Revier Therapeutics · $7 million · Seed · August 25, 2026
• Brain-Device Era · an undisclosed amount · Seed · August 24, 2026
• RevealDx · $3.4 million · Strategic Investment · August 9, 2026
• Lycia Therapeutics · $75 million · Funding Round · July 29, 2026
• Photon Queue · $4 million · Seed · July 23, 2026
• Photon Queue · $4 million · Seed · July 21, 2026
• Assort Health · $120 million · Series C · July 15, 2026
• Beeline Medicines · $126.3 million · Series A Extension · July 6, 2026
• Callie Care · $500 thousand · Pre-Seed · July 6, 2026

Market context

Healthcare & Life Sciences deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.